See more : Glenveagh Properties PLC (GLVHF) Income Statement Analysis – Financial Results
Complete financial analysis of Retractable Technologies, Inc. (RVP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Retractable Technologies, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Aptech Limited (APTECHT.BO) Income Statement Analysis – Financial Results
- Yuan Cheng Cable Co.,Ltd. (002692.SZ) Income Statement Analysis – Financial Results
- Hatsuho Shouji Co.,Ltd. (7425.T) Income Statement Analysis – Financial Results
- Kontron AG (KTN.DE) Income Statement Analysis – Financial Results
- OPTeam Spólka Akcyjna (OPM.WA) Income Statement Analysis – Financial Results
Retractable Technologies, Inc. (RVP)
About Retractable Technologies, Inc.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.60M | 94.82M | 188.38M | 81.86M | 41.80M | 33.27M | 34.49M | 29.83M | 29.55M | 34.52M | 30.79M | 33.64M | 32.10M | 36.22M | 38.98M | 27.90M | 26.29M | 25.32M | 24.24M | 21.52M | 19.08M | 20.32M | 16.15M | 9.64M |
| Cost of Revenue | 34.49M | 66.57M | 93.03M | 44.85M | 27.66M | 23.05M | 24.52M | 19.48M | 18.99M | 22.50M | 20.48M | 22.47M | 21.20M | 23.82M | 25.47M | 19.67M | 18.30M | 17.78M | 15.43M | 16.41M | 14.65M | 14.99M | 13.32M | 7.88M |
| Gross Profit | 9.11M | 28.25M | 95.35M | 37.01M | 14.14M | 10.22M | 9.97M | 10.34M | 10.57M | 12.02M | 10.31M | 11.18M | 10.90M | 12.40M | 13.52M | 8.23M | 7.99M | 7.55M | 8.81M | 5.11M | 4.42M | 5.33M | 2.82M | 1.76M |
| Gross Profit Ratio | 20.89% | 29.80% | 50.62% | 45.21% | 33.83% | 30.72% | 28.91% | 34.67% | 35.75% | 34.82% | 33.49% | 33.22% | 33.96% | 34.25% | 34.67% | 29.49% | 30.39% | 29.80% | 36.34% | 23.75% | 23.19% | 26.21% | 17.48% | 18.30% |
| Research & Development | 581.17K | 525.73K | 901.38K | 574.53K | 516.10K | 621.37K | 740.57K | 571.84K | 607.53K | 616.78K | 837.07K | 871.85K | 815.02K | 885.45K | 1.03M | 1.07M | 1.07M | 958.80K | 934.21K | 626.94K | 561.14K | 337.93K | 756.54K | 899.15K |
| General & Administrative | 14.31M | 24.04M | 17.38M | 8.30M | 6.43M | 6.78M | 8.35M | 8.80M | 9.33M | 9.60M | 10.99M | 10.02M | 10.74M | 14.26M | 18.81M | 12.77M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 0.00 | 0.00 |
| Selling & Marketing | 5.71M | 4.54M | 4.48M | 4.06M | 4.22M | 4.40M | 4.66M | 4.03M | 3.84M | 3.97M | 4.41M | 4.22M | 3.44M | 3.67M | 4.37M | 4.84M | 5,299.16B | 5.55B | 4.15B | 3.65M | 3.37M | 4.04M | 0.00 | 0.00 |
| SG&A | 20.01M | 28.58M | 21.86M | 12.36M | 10.65M | 11.18M | 13.01M | 12.82M | 13.17M | 13.56M | 15.40M | 14.24M | 14.18M | 17.93M | 23.19M | 17.61M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 8.78M | 10.37M |
| Other Expenses | 0.00 | -3.83M | -425.16K | 0.00 | 0.00 | 0.00 | 0.00 | 456.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 365.30M | 2,594.60B | 18.67B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.32M | 8.78M | 10.37M |
| Operating Expenses | 20.60M | 25.27M | 22.33M | 12.94M | 11.17M | 11.80M | 13.75M | 13.39M | 13.77M | 14.18M | 16.24M | 15.12M | 14.99M | 18.82M | 24.22M | 18.67M | 17.94M | 14.26M | 11.68M | 13.11M | 10.33M | 11.23M | 9.54M | 11.27M |
| Cost & Expenses | 55.09M | 91.84M | 115.36M | 57.79M | 38.83M | 34.86M | 38.27M | 32.88M | 32.76M | 36.68M | 36.72M | 37.58M | 36.19M | 42.63M | 49.68M | 38.34M | 36.24M | 32.04M | 27.11M | 29.52M | 24.98M | 26.22M | 22.86M | 19.15M |
| Interest Income | 1.45M | 9.95K | 780.00K | 2.26M | 351.17K | 144.12K | 65.70K | 26.52K | 24.92K | 33.94K | 38.94K | 47.00K | 62.60K | 32.32K | 57.60K | 855.69K | 1.87M | 1.98M | 1.37M | 475.12K | 44.55K | 10.04K | 51.94K | 204.20K |
| Interest Expense | 152.17K | 170.65K | 227.18K | 260.26K | 166.90K | 177.19K | 210.76K | 213.30K | 219.67K | 222.81K | 230.58K | 231.21K | 240.48K | 302.84K | 21.89K | 54.36K | 326.30K | 411.15K | 339.69K | 243.92K | 307.14K | 446.39K | 553.62K | 203.78K |
| Depreciation & Amortization | 7.53M | 4.60M | 1.26M | 832.07K | 852.08K | 886.81K | 834.95K | 872.87K | 858.39K | 1.07M | 1.28M | 1.34M | 1.31M | 1.52M | 1.40M | 1.40M | 1.43M | 1.43M | 1.37M | 1.29M | 1.31M | 1.33M | 1.20M | 938.57K |
| EBITDA | -1.24M | 9.94M | 76.44M | 27.17M | 4.18M | -289.26K | -2.88M | -2.61M | 5.40M | -1.05M | -4.61M | -2.56M | 2.98M | 4.04M | -11.84M | -8.19M | -6.66M | -3.31M | -137.09K | -8.00M | -4.59M | -4.58M | -5.52M | -8.57M |
| EBITDA Ratio | -2.84% | 8.01% | 39.84% | 33.18% | 9.99% | -1.65% | -8.34% | -7.21% | -7.87% | -3.04% | -14.97% | -7.60% | -8.46% | -13.44% | -23.72% | -29.36% | -32.39% | -20.88% | -6.23% | -377.94% | -96.83% | -8.75% | -34.17% | -88.87% |
| Operating Income | -11.49M | 2.99M | 72.60M | 24.07M | 2.97M | -1.32M | -3.78M | -3.51M | -3.21M | -2.16M | -5.93M | -3.94M | -4.09M | -6.78M | -13.30M | -10.44M | -9.95M | -6.71M | -2.88M | -8.00M | -5.90M | -6.39M | -6.71M | -10.45M |
| Operating Income Ratio | -26.35% | 3.15% | 38.54% | 29.40% | 7.11% | -3.97% | -10.95% | -11.76% | -10.85% | -6.25% | -19.27% | -11.71% | -12.74% | -18.72% | -34.11% | -37.44% | -37.83% | -26.51% | -11.87% | -37.17% | -30.94% | -31.45% | -41.58% | -108.33% |
| Total Other Income/Expenses | 2.57M | 6.02M | 2.36M | 2.00M | 184.27K | 236.78K | -145.07K | -642.89K | 7.53M | -188.87K | -191.64K | -184.21K | 5.52M | 8.64M | -2.56M | 801.33K | 1.54M | 1.57M | 1.03M | 74.87M | 13.62M | -436.36K | 0.00 | 734.79K |
| Income Before Tax | -8.92M | 5.16M | 74.95M | 26.07M | 3.16M | -1.35M | -3.92M | -3.69M | 4.32M | -2.35M | -6.12M | -4.12M | 1.43M | 2.22M | -13.26M | -9.64M | -8.40M | -5.15M | -1.84M | 66.87M | 7.71M | -6.83M | 0.00 | 0.00 |
| Income Before Tax Ratio | -20.45% | 5.44% | 39.79% | 31.85% | 7.55% | -4.07% | -11.37% | -12.38% | 14.63% | -6.80% | -19.89% | -12.25% | 4.46% | 6.14% | -34.02% | -34.57% | -31.96% | -20.33% | -7.61% | 310.70% | 40.43% | -33.60% | 0.00% | 0.00% |
| Income Tax Expense | -1.91M | 83.87K | 18.89M | 1.85M | 7.88K | -13.32K | -187.61K | 1.13K | 7.88K | 8.18K | 90.97K | 9.82K | 13.80K | -176.06K | -3.84M | 855.69K | -1.45M | -1.28M | -605.36K | 12.18M | 265.47K | 917.99K | 501.67K | 938.15K |
| Net Income | -7.01M | 5.08M | 56.06M | 24.22M | 3.15M | -1.34M | -3.74M | -3.69M | 4.31M | -2.35M | -6.21M | -4.13M | 1.42M | 2.40M | -9.42M | -9.64M | -6.95M | -3.87M | -1.24M | 54.69M | 7.45M | -6.83M | -7.22M | -10.44M |
| Net Income Ratio | -16.08% | 5.36% | 29.76% | 29.59% | 7.53% | -4.03% | -10.83% | -12.39% | 14.60% | -6.82% | -20.18% | -12.28% | 4.42% | 6.63% | -24.17% | -34.57% | -26.43% | -15.28% | -5.11% | 254.12% | 39.04% | -33.60% | -44.69% | -108.33% |
| EPS | -0.24 | 0.15 | 1.65 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.21 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.23 | -0.34 | -0.36 | -0.71 |
| EPS Diluted | -0.24 | 0.15 | 1.63 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.20 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.20 | -0.34 | -0.36 | -0.54 |
| Weighted Avg Shares Out | 29.94M | 32.90M | 33.87M | 33.17M | 32.67M | 32.67M | 31.72M | 29.33M | 27.82M | 27.25M | 27.00M | 26.22M | 24.17M | 23.87M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 22.60M | 21.00M | 20.30M | 19.77M | 14.72M |
| Weighted Avg Shares Out (Dil) | 29.94M | 32.96M | 34.24M | 33.30M | 32.67M | 32.67M | 31.96M | 29.35M | 29.48M | 27.38M | 27.00M | 26.22M | 26.35M | 26.25M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 25.48M | 24.44M | 20.30M | 19.77M | 19.37M |
Retractable Technologies, Inc. Declares Dividends to Series II Class B Convertible Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B Convertible Preferred Stock in the amount of $39,050. The dividend amount is $0.25...
Retractable Technologies: Unfairly Punished, ~27% Upside Potential Under-Reflected
Retractable Technologies is a name that continues to fly under the radar of analysts and investors alike. The company's segment revenue and FCFF conversion have exhibited stellar growth in the last 2-4 year period, with 94% FCFF conversion from the...
2 Evergreen Value Stocks You Could Buy and Hold Forever
Their products are never going out of style, and their valuations are attractive.
Retractable Technologies, Inc. Reports $36.1 Million in Operating Income for the First Six Months Of 2021
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $36.1 million for the first six months of 2021, compared to an operating income for the same period last year of $1.4 million, and that...
3 Value Stocks That Won't Stop Growing
Their business models are timeless, and their revenue is rising.
Retractable Technologies, Inc. Amends HHS Delivery Order
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that it has entered into an amendment to delivery order 75A50120F33003 from the Department of Health and Human Services which was awarded May 1, 2020. The amendment changes the...
RVP Stock Price: Over 10% Increase Explanation
The stock price of Retractable Technologies, Inc. (NYSEAMERICAN: RVP) increased by over 10%. This is why it happened.
Retractable Technologies, Inc. Receives Notice of Intent to Extend Government Contract
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that, in accordance with the 30 day notice requirement, it received a preliminary notice from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for...
Retractable Technologies, Inc. to Receive Additional Funding From U.S. Government Under Technology Investment Agreement
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies Inc. (NYSE American: RVP) announced today that it has entered into an amendment to the Technology Investment Agreement (originally awarded on July 1, 2020) with the U.S. government providing $27,365,232 in additional funding. The amendment...
3 Most-Shorted Stocks Ready to Buy Today
It's time to reacquaint your trading account with a better investment today in three of the market's most-shorted stocks. The post 3 Most-Shorted Stocks Ready to Buy Today appeared first on InvestorPlace.
Source: https://incomestatements.info
Category: Stock Reports